Atossa Genetics Common Stock Net 2012-2025 | ATOS
Atossa Genetics common stock net from 2012 to 2025. Common stock net can be defined as the value of common equity ownership.
| Atossa Genetics Annual Common Stock Net (Millions of US $) |
|
|---|---|
| 2024 | $23 |
| 2023 | $23 |
| 2022 | $23 |
| 2021 | $23 |
| 2020 | $9 |
| 2019 | $2 |
| 2018 | $1 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
| Atossa Genetics Quarterly Common Stock Net (Millions of US $) |
|
|---|---|
| 2025-03-31 | $23 |
| 2024-12-31 | $23 |
| 2024-09-30 | $23 |
| 2024-06-30 | $23 |
| 2024-03-31 | $23 |
| 2023-12-31 | $23 |
| 2023-09-30 | $23 |
| 2023-06-30 | $23 |
| 2023-03-31 | $23 |
| 2022-12-31 | $23 |
| 2022-09-30 | $23 |
| 2022-06-30 | $23 |
| 2022-03-31 | $23 |
| 2021-12-31 | $23 |
| 2021-09-30 | $23 |
| 2021-06-30 | $23 |
| 2021-03-31 | $22 |
| 2020-12-31 | $9 |
| 2020-09-30 | $2 |
| 2020-06-30 | $2 |
| 2020-03-31 | $2 |
| 2019-12-31 | $2 |
| 2019-09-30 | $2 |
| 2019-06-30 | $2 |
| 2019-03-31 | $2 |
| 2018-12-31 | $1 |
| 2018-09-30 | $1 |
| 2018-06-30 | $1 |
| 2018-03-31 | $0 |
| 2017-12-31 | $0 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-03-31 | $0 |
| 2015-12-31 | $0 |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $0 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $0 |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2013-03-31 | $0 |
| 2012-12-31 | $0 |
| 2012-09-30 | $0 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | |
| 2011-09-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.104B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $176.126B | 21.31 |
| Intuitive Surgical (ISRG) | United States | $170.993B | 70.88 |
| IDEXX Laboratories (IDXX) | United States | $51.626B | 53.45 |
| Edwards Lifesciences (EW) | United States | $46.482B | 30.83 |
| Alcon (ALC) | Switzerland | $42.192B | 28.51 |
| IQVIA Holdings (IQV) | United States | $31.268B | 17.67 |
| DexCom (DXCM) | United States | $29.592B | 44.39 |
| Mettler-Toledo (MTD) | United States | $25.624B | 30.41 |
| STERIS (STE) | Ireland | $22.022B | 24.25 |
| Waters (WAT) | United States | $16.738B | 22.99 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.353B | 0.00 |
| Hologic (HOLX) | United States | $15.084B | 16.34 |
| Sysmex ADR (SSMXY) | Japan | $10.519B | 29.84 |
| Penumbra (PEN) | United States | $9.364B | 68.40 |
| Masimo (MASI) | United States | $8.885B | 29.96 |
| Globus Medical (GMED) | United States | $7.262B | 17.30 |
| Teleflex (TFX) | United States | $5.076B | 8.19 |
| Glaukos (GKOS) | United States | $5.050B | 0.00 |
| TransMedics (TMDX) | United States | $4.287B | 65.15 |
| Integer Holdings (ITGR) | United States | $3.774B | 18.83 |
| PROCEPT BioRobotics (PRCT) | United States | $2.662B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.323B | 13.83 |
| Alphatec Holdings (ATEC) | United States | $2.270B | 0.00 |
| Veracyte (VCYT) | United States | $1.959B | 27.48 |
| Nihon Kohden (NHNKY) | Japan | $1.942B | 22.27 |
| Elekta AB (EKTAY) | Sweden | $1.839B | 16.53 |
| Artivion (AORT) | United States | $1.373B | 128.60 |
| Pulse Biosciences (PLSE) | United States | $1.026B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.009B | 0.00 |
| OPKO Health (OPK) | United States | $1.000B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.992B | 5.68 |
| IRadimed (IRMD) | United States | $0.885B | 42.94 |
| Beta Bionics (BBNX) | United States | $0.687B | 0.00 |
| SiBone (SIBN) | United States | $0.682B | 0.00 |
| AxoGen (AXGN) | United States | $0.625B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.516B | 4.15 |
| OrthoPediatrics (KIDS) | United States | $0.490B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.482B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.457B | 8.11 |
| Pacific Biosciences Of California (PACB) | United States | $0.426B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.366B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.352B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.352B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.316B | 8.03 |
| RxSight (RXST) | United States | $0.311B | 0.00 |
| Neuronetics (STIM) | United States | $0.300B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.295B | 0.00 |
| NeuroPace (NPCE) | United States | $0.285B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.280B | 19.29 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| 908 Devices (MASS) | United States | $0.227B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.194B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.180B | 0.00 |
| CVRx (CVRX) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.176B | 0.00 |
| Inogen (INGN) | United States | $0.170B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.150B | 0.00 |
| Accuray (ARAY) | United States | $0.146B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.137B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.126B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.108B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.105B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.093B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.086B | 52.50 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| Spectral AI (MDAI) | United States | $0.061B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.055B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.047B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.013B | 0.00 | |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 12.92 |